Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DESOGESTREL vs DEUCRAVACITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DESOGESTREL vs DEUCRAVACITINIB: Safety Overview

Metric DESOGESTREL DEUCRAVACITINIB
Total FAERS Reports 592 2,386
Deaths Reported 29 36
Death Rate 4.9% 1.5%
Hospitalizations 242 121
Average Patient Age 33.5 yrs 56.8 yrs
% Female Patients 96.4% 63.8%
FDA Approval Date N/A Sep 9, 2022
Manufacturer N/A E.R. Squibb & Sons, L.L.C.
Route N/A ORAL
Marketing Status N/A Prescription